bf/NASDAQ:LUMO_icon.png

NASDAQ:LUMO

Lumos Pharma, Inc.

  • Stock

USD

Last Close

3.92

25/09 14:34

Market Cap

14.37M

Beta: 0.65

Volume Today

1.09K

Avg: 11.78K

PE Ratio

−0.78

PFCF: −0.81

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.09M
-
165.95M
15,082.98%
36.14M
78.22%
3.53M
90.24%
390K
88.94%
1.21M
209.23%
936K
22.39%
168K
82.05%
230K
36.90%
1.52M
562.17%
2.05M
34.67%
cost of revenue
-11.27M
-
37K
100.33%
49K
-
44K
10.20%
gross profit
1.09M
-
172.59M
15,690.67%
68.50M
60.31%
3.53M
94.85%
390K
88.94%
12.47M
3,098.46%
899K
92.79%
168K
81.31%
230K
36.90%
1.47M
540.87%
2.01M
36.16%
selling and marketing expenses
-44.00K
-
general and administrative expenses
9.52M
-
19.33M
103.00%
30.69M
58.78%
33.23M
8.27%
31.73M
4.51%
29.22M
7.91%
23.86M
18.32%
17.27M
27.66%
15.33M
11.20%
15.71M
2.45%
16.57M
5.49%
selling general and administrative expenses
9.52M
-
19.33M
103.00%
30.69M
58.78%
33.23M
8.27%
31.73M
4.51%
29.22M
7.91%
23.86M
18.32%
17.27M
27.66%
15.33M
11.20%
15.71M
2.45%
16.52M
5.21%
research and development expenses
22.71M
-
35.69M
57.14%
71.41M
100.09%
93.30M
30.65%
69.87M
25.12%
45.69M
34.60%
22.20M
51.40%
9.21M
58.54%
16.25M
76.47%
17.86M
9.92%
22.10M
23.74%
other expenses
91K
-
60K
34.07%
-41K
168.33%
247K
702.44%
371K
50.20%
-102K
127.49%
-19K
81.37%
6.47M
34,136.84%
269K
95.84%
91K
66.17%
683K
650.55%
cost and expenses
31.14M
-
48.38M
55.35%
69.75M
44.17%
94.28M
35.18%
73.27M
22.29%
63.64M
13.14%
46.07M
27.61%
26.47M
42.54%
31.58M
19.29%
33.56M
6.29%
38.66M
15.20%
operating expenses
31.14M
-
48.38M
55.35%
69.75M
44.17%
94.28M
35.18%
73.27M
22.29%
63.64M
13.14%
46.07M
27.61%
26.47M
42.54%
31.58M
19.29%
33.56M
6.29%
38.62M
15.07%
interest expense
33K
-
26K
21.21%
105K
303.85%
22K
79.05%
119K
440.91%
52K
56.30%
50K
3.85%
874K
-
ebitda
-31.14M
-
117.57M
477.55%
-33.60M
128.58%
-90.76M
170.10%
-72.88M
19.70%
-60.51M
16.97%
-42.93M
29.06%
-26.30M
38.73%
-31.35M
19.18%
-32.04M
2.21%
-36.57M
14.14%
operating income
-31.14M
-
117.57M
477.55%
-33.60M
128.58%
-90.76M
170.10%
-72.88M
19.70%
-62.44M
14.33%
-45.13M
27.71%
-26.30M
41.72%
-31.35M
19.18%
-32.04M
2.21%
-36.61M
14.28%
depreciation and amortization
891K
-
1.10M
23.12%
1.59M
45.12%
2.08M
30.90%
1.41M
32.49%
1.15M
18.62%
2.21M
92.75%
584K
73.54%
203K
65.24%
49K
75.86%
44K
10.20%
total other income expenses net
91K
-
60K
34.07%
-41K
168.33%
247K
702.44%
371K
50.20%
-102K
127.49%
2.16M
2,214.71%
6.67M
209.09%
281K
95.79%
965K
243.42%
2.55M
164.35%
income before tax
-31.05M
-
117.63M
478.85%
-33.64M
128.60%
-90.51M
169.03%
-72.51M
19.89%
-60.56M
16.48%
-42.98M
29.04%
-19.64M
54.31%
-31.07M
58.21%
-31.07M
0.03%
-34.06M
9.62%
income tax expense
130K
-
14.78M
11,265.38%
6.74M
54.40%
-5.36M
179.49%
-559K
89.56%
-6.97M
1,146.51%
12K
100.17%
-13.97M
116,541.67%
-636K
95.45%
-13K
97.96%
-29K
123.08%
net income
-31.18M
-
102.86M
429.88%
-40.38M
139.26%
-85.16M
110.88%
-71.95M
15.51%
-53.59M
25.51%
-42.99M
19.79%
-5.66M
86.83%
-30.43M
437.35%
-31.06M
2.08%
-34.03M
9.57%
weighted average shs out
2.81M
-
3.09M
10.14%
3.18M
2.69%
3.22M
1.37%
3.48M
8.02%
4.13M
18.81%
144.71K
96.50%
6.78M
4,583.84%
8.33M
22.97%
8.37M
0.47%
8.15M
2.73%
weighted average shs out dil
2.81M
-
3.45M
22.75%
3.18M
7.86%
3.22M
1.37%
3.48M
8.02%
4.13M
18.81%
144.71K
96.50%
6.78M
4,583.84%
8.33M
22.97%
8.37M
0.47%
8.15M
2.73%
eps
-11.10
-
31.05
379.73%
-12.71
140.93%
-26.45
108.10%
-20.69
21.78%
-12.97
37.31%
-297.07
2,190.44%
-0.84
99.72%
-3.65
334.52%
-3.71
1.64%
-4.18
12.67%
epsdiluted
-11.10
-
27.81
350.54%
-12.71
145.70%
-26.45
108.10%
-20.69
21.78%
-12.97
37.31%
-297.07
2,190.44%
-0.84
99.72%
-3.65
334.52%
-3.71
1.64%
-4.18
12.67%

All numbers in USD (except ratios and percentages)